Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2005
10/27/2005CA2562526A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/27/2005CA2562406A1 Cyclic amine compound
10/27/2005CA2562244A1 Cyclic compounds
10/27/2005CA2561315A1 Inhibitors of akt activity
10/26/2005EP1587810A1 Novel substituted 1,4]benzodioxino 2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
10/26/2005EP1587806A1 Pyrimido 5,4-e] 1,2,4]triazine-5,7-diones, methods for producing the same and their use
10/26/2005EP1587796A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands
10/26/2005EP1587786A1 2.4-DIHALOGEN-6-(C sb 2 /sb -C sb 3 /sb -ALKYL)-PHENYL SUBSTITUTED TETRAMIC ACID DERIVATIVES
10/26/2005EP1587480A2 Polyhydroxylated pyrrolizidine
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1450790A4 Photosensitizing carbamate derivatives
10/26/2005EP1450774A4 Chlorin photosensitizing agents for use in photodynamic therapy
10/26/2005EP1430056B1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders
10/26/2005EP1381607B1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005CN1688584A Selective d1/d5 receptor antagonists for the treatment of obesity and CNS disorders
10/26/2005CN1688583A Organic compounds as agents for the treatment of aldosterone mediated conditions
10/26/2005CN1688582A Fused azole-pyrimidine derivatives
10/26/2005CN1688581A [1, 2, 4]-triazole bicyclic adenosine A2a receptor antagonists
10/26/2005CN1688573A Pyrrole based inhibitors of glycogen synthase kinase 3
10/26/2005CN1688311A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
10/26/2005CN1687070A Sinomenine derivative with C cycle connected to penetabasic heterocycle and synthesizing method
10/26/2005CN1687069A Method for extracting vitamine B2
10/26/2005CN1687068A Method for total synthesizing bromization derivative pyrrole hetero ring alkaloid
10/25/2005US6958397 catalysis of single starting material, piperazine over zeolite (silica and one oxide of a trivalent or tetravalent metal); by product inhibition, catalyst selctivity
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/25/2005US6958342 For use as sedative-hypnotic, anxiolytic, anticonvulsant, and skeletal muscle relaxant agent in treatment of insomnia; differential scanning calorimetry
10/25/2005US6958341 Pyrazolopyrimidines as CRF antagonists
10/25/2005US6958334 Akt, is a serine/threonine protein kinase; 2,2,N,N-tetramethyl-N-(3-phenyl-[1,2,4]triazolo[3,4-alpha]phthalazin-6-yl)-propane-1,3-diamine for example; anticancer agents
10/25/2005US6958333 N'-(isoindolino[3,2-b]perhydro-1,3-oxazin-5-on-9-yl)-N-(pyridin-2-yl) urea, for example; cyclin-dependent kinase inhibitors; colon cancer treatment
10/25/2005US6958330 useful as synthetic intermediates in the preparation of inhibitors of beta-amyloid peptide release described in U.S. patent application Ser. No. 08/996,422; 5-amino-7-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one for example
10/25/2005US6958205 Image forming material and ammonium compound
10/25/2005CA2284879C Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
10/20/2005WO2005097806A1 Compounds and methods for treating dyslipidemia
10/20/2005WO2005097805A1 Compounds and methods for treating dyslipidemia
10/20/2005WO2005097800A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
10/20/2005WO2005097799A1 Pyrazolo`4,3-d! pyrimidines
10/20/2005WO2005097798A1 Novel 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones, production and use thereof as medicaments
10/20/2005WO2005097797A2 Compounds with atypical antipsychotic activity
10/20/2005WO2005097796A2 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
10/20/2005WO2005097793A1 An improved process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
10/20/2005WO2005097791A1 Inhibitors of iap
10/20/2005WO2005097768A2 Novel gamma secretase inhibitors
10/20/2005WO2005097733A1 Process for the preparation of enantiomerically enriched beta amino acid derivatives
10/20/2005WO2005097713A1 Fluoridation method
10/20/2005WO2005097123A2 Pyridyl-substituted porphyrin compounds and methods of use thereof
10/20/2005WO2005097107A2 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005046590A3 Methods for synthesizing quinolinone compounds
10/20/2005WO2004071460A3 Cyclic derivatives as modulators of chemokine receptor activity
10/20/2005US20050234243 Novel diketopyrrolopyrrole pigments
10/20/2005US20050234237 reacting 3-dimethylamino-1-(3-N-ethyl-N-acetylaminophenyl)-2-propen-1-one with 3-aminopyrazole-4-carbonitrile in aqueous solution of formic acid; for use as anxiolytic, sedative, and skeletal muscle relaxing agent
10/20/2005US20050234235 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234092 Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
10/20/2005US20050234090 Modulators of chemokine receptor activity
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234076 Triazolopyrimidines
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234064 2-(4-Methoxyphenyl)-amino-),3-(aminocarbonyl-)quinoxaline; janus(JAK) kinase inhibitors;spleen tyrosine kinase(SYK) inhibitors; glycogen synthase-3(GSK-3) kinase inhibitors; immunocompetance; antiinflammatory agents; antiallergens; autoimmune diseases; antiproliferative agents; respiratory disorders
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234060 Pyrrolotriazine kinase inhibitors
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005US20050234042 Organic compounds
10/20/2005US20050234034 One of the ring nitrogens is carbonyl-substituted, e.g., 2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[5-(2,4-dichloro-benzyl)-hexahydropyrrolo[3,4-c]pyrrol-2-yl]ethanone; inflammatory disorders (rheumatoid arthritis, multiple sclerosis)and immune disorders (transplant rejection)
10/20/2005US20050234032 Antibacterial compositions comprising metal phthalocyanine analogues
10/20/2005US20050234031 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders
10/20/2005US20050234022 Use of 2-alkoxyphenyl-substituted imidazotriazinones
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/20/2005DE10393651T5 Polymerisierbare Verbindungen mit Gruppen, die vier Wasserstoffbrückenbindungen ausbilden Polymerizable compounds with groups that form four hydrogen bonds
10/20/2005CA2563033A1 Novel gamma secretase inhibitors
10/20/2005CA2562780A1 Nucleic acid melting analysis with saturation dyes
10/20/2005CA2562399A1 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005CA2561973A1 Process for the preparation of enantiomerically enriched beta amino acid derivatives
10/20/2005CA2561266A1 Pyridyl-substituted porphyrin compounds and methods of use thereof
10/20/2005CA2561210A1 Novel 2-amino-imidazo[4,5-d]pyridazin-4-ones and 2-amino-imidazo[4,5-c]pyridin-4-ones, production and use thereof as medicaments
10/20/2005CA2560162A1 Inhibitors of iap
10/20/2005CA2558817A1 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
10/20/2005CA2557010A1 Compounds and methods for treating dyslipidemia
10/20/2005CA2555859A1 Compounds with atypical antipsychotic activity
10/19/2005EP1585749A1 Diazepinoindole derivatives as kinase inhibitors
10/19/2005EP1585748A1 PYRAZOLO 3,4-d PYRIMIDINE DERIVATIVES AND THEIR USE I N THE TREATMENT OF H.PYLORI INFECTION
10/19/2005EP1585747A1 5-alkyl-7-aminotriazolopyrimidines, methods and intermediary products necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms
10/19/2005EP1585522A2 Quinazolinones as potassium channel modulators
10/19/2005EP1585481A2 Pyrazolopyrimidine compound and process for preparing the same
10/19/2005EP1406902B1 Hexahydroazepino[4,5-g]indoles and indolines as 5-ht receptor ligands
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1272493B1 A process for the preparation of decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene and functionalized derivatives
10/19/2005EP1152061B1 Method for screening physiologically active pyrrole imidazole derivative
10/19/2005EP0831891B1 Oxidant scavengers
10/19/2005CN1684955A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1683371A Substituted purine and substituted 1, 2, 3-trizole pyrimidine new compound with anti-HIV activity, rpeparing method and use
10/19/2005CN1683336A Process for synthesizing acyl imidogen substituted cyclo compound
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/18/2005US6956041 Protein kinase inhibitors
10/13/2005WO2005095408A1 Polynuclear metal complex having ligand with cage configuration
10/13/2005WO2005095407A1 M3 muscarinic acetylcholine receptor antagonists
1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 573